Aspen Aerogels (NYSE:ASPN – Free Report) had its price target lowered by Barclays from $27.00 to $25.00 in a research report released on Tuesday,Benzinga reports. The firm currently has an overweight rating on the construction company’s stock.
Several other research analysts have also recently issued reports on ASPN. HC Wainwright reissued a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a research report on Wednesday, October 16th. Roth Mkm reduced their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a report on Friday, November 8th. Piper Sandler decreased their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Benchmark reissued a “buy” rating and set a $14.00 price objective on shares of Aspen Aerogels in a research report on Thursday, August 8th. Finally, TD Cowen raised their target price on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, August 20th. One analyst has rated the stock with a sell rating, nine have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $28.70.
Check Out Our Latest Analysis on ASPN
Aspen Aerogels Price Performance
Insider Buying and Selling
In related news, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the transaction, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This trade represents a 11.58 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the sale, the chief financial officer now owns 20,790 shares in the company, valued at approximately $626,610.60. This represents a 60.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Aspen Aerogels
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Point72 Hong Kong Ltd bought a new position in Aspen Aerogels during the second quarter valued at $84,000. nVerses Capital LLC purchased a new stake in shares of Aspen Aerogels during the 2nd quarter valued at about $95,000. Quent Capital LLC bought a new position in shares of Aspen Aerogels in the 3rd quarter valued at about $118,000. Point72 DIFC Ltd purchased a new position in Aspen Aerogels in the second quarter worth about $121,000. Finally, Public Employees Retirement Association of Colorado purchased a new position in Aspen Aerogels in the second quarter worth about $145,000. 97.64% of the stock is owned by institutional investors.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories
- Five stocks we like better than Aspen Aerogels
- 3 Fintech Stocks With Good 2021 Prospects
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Insider Trading – What You Need to Know
- Top-Performing Non-Leveraged ETFs This Year
- Top Biotech Stocks: Exploring Innovation Opportunities
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.